TinyGemsBreaks Archive - Page 79 of 124

MondayFeb 06, 2023 10:43 am

TinyGemsBreaks — Cepton Inc. (NASDAQ: CPTN) Wins Largest Commercial Lidar Deployment Contract in Tolling Sector to Date

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has been awarded a multimillion sales contract from one of the leading U.S. highway tolling systems in the country. The company announced that its exclusive, state-of-the-art lidar solution will be deployed nationwide; the contract is designed to improve and enable accurate and intelligent tolling applications. According to the announcement, the large-scale contract calls for CPTN’s Sora series lidar sensors to be positioned on several major tollways located in the Tri-State area and Northern California in what is projected to be the largest commercial lidar deployment in the tolling…

FridayFeb 03, 2023 11:50 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Pleased with Early Results from Global Clinical Trial

CNS Pharmaceuticals (NASDAQ: CNSP) recently reported that 67 patients have enrolled in the potentially pivotal phase 2 globally cited clinical study comparing drug candidate Berubicin’s effectiveness to second-line standard-of-care chemotherapy drug Lomustine. “The company plans to have more than 200 patients participate in the clinical trial on a 2:1 randomization schema between those receiving Berubicin and those receiving Lomustine… Berubicin’s performance in an initial safety trial conducted by another company in 2006 resulted in apparent life extension for some patients and complete remission for one patient who, unusually, survives nearly 17 years later. The ongoing study now seeks to demonstrate…

ThursdayFeb 02, 2023 1:57 pm

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Partners with Loop Global, Menzies Aviation on LAX Pilot Program

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is collaborating with Menzies Aviation and Loop Global Inc. on a pilot program at the Los Angeles International Airport; the program involves Mullen’s Class 1 EV cargo vans. The world’s largest aviation services company, Menzies operates in 250-plus airports in 58 countries, providing ground, air cargo and fuel services to commercial airports and airlines. Menzies is piloting Mullen Automotive electric vans and Loop Global charging infrastructure across its operations at LAX; the program is part of Menzies commitment to identify innovative solutions as it works to become carbon neutral by…

ThursdayFeb 02, 2023 1:26 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Shown to Elevate Drug Delivery Across Blood-Brain Barrier by ~1,900%

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, has developed its patented DehydraTECH(TM) technology, which is designed for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. “DehydraTECH increases effectiveness and improves how these ingredients enter the bloodstream. Benefits of DehydraTECH include: improved speed of onset, with effects felt in minutes; increased bioavailability, with more of the drug delivered into the bloodstream; increased brain absorption, with testing suggesting up to 10x improvement; and improved drug potency, with more of the ingested product made available in the bloodstream requiring lower dosages,” a recent article reads. “Animal studies…

WednesdayFeb 01, 2023 11:14 am

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Receives Approval for First-in-Human Dosing of Proprietary DMT Molecule

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has received key approval to initiate human dosing of CYB004, its proprietary deuterated N,N-dimethyltryptamine (“DMT”) molecule, through a protocol amendment to its ongoing CYB004-E phase 1 trial. The approval came from an independent ethics committee in the Netherlands. The first-ever trial that evaluates deuterated DMT in humans, the study is being conducted at the Centre for Human Drug Research in the Netherlands; it is the largest-ever Phase 1 DMT trial conducted to date. Based on previous studies, CYB004 has shown potential to deliver an improved bioavailability…

TuesdayJan 31, 2023 12:00 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT), Fr8App Partners with Leading Mexico-Based Trucking Company to Expand Services

Freight Technologies (NASDAQ: FRGT), a technology company whose custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning and offers a real-time portal for B2B cross-border shipping and domestic shipping within the USMCA region, is partnering with a leading transportation company in Mexico: Majoba Logistics. Fr8App is onboarding MAJOBA Logistics with an eye on expanding transportation capacity for its private fleet service. According to the announcement, Majoba Logistics’ fleet of vehicles will be added to the Fr8App platform in a move that provides a wider range of transportation options as well as more efficient and cost-effective services to customers.…

TuesdayJan 31, 2023 11:19 am

TinyGemsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Board Authorizes Stock Repurchase Program

Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, has announced a stock repurchase program. According to the company, its board of directors has approved the program, which will acquire up to $1 million of the company's common stock. The announcement noted that the company could purchase common stock in a variety of ways, including in the open market and through privately negotiated transactions; all transactions will be in compliance with United States Securities and Exchange Commission rules and guidelines. The repurchase of stocks will depend on available liquidity, cash flows and market conditions…

MondayJan 30, 2023 12:15 pm

TinyGemsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Releases FY 2022 Financial Numbers, Reports Record Revenue

Golden Matrix Group (NASDAQ: GMGI), a developer, licensor and global operator of online gaming and eCommerce platforms, systems, and gaming content, has released a financial report for FY 2022, the year ended Oct. 31, 2022. Highlights of the report included full-year revenues of $36 million, a 219% increase from the previous year and a revenue record for the company. The report also showed Adjusted EBITDA of more than $3.5 million, cash and cash equivalents of $14.9 million, total assets of $32.5 million and total liabilities of $2,774,932. In addition, the company reported shareholders equity had increased 42%, from $18.9 million in…

MondayJan 30, 2023 10:50 am

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Announces Participation at Upcoming Conferences

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced its participation in conferences taking place in February 2023. Cepton’s CEO Dr. Jun Pei and CFO Hull Xu will take part in a fireside chat starting at 1:10 p.m. ET on Feb. 15 at the Baird 2023 Vehicle Technology & Mobility Conference, which is being held in a virtual format. In addition, Cepton will participate in the Citi 2023 Global Industrial Tech & Mobility Conference slated to take place on Feb. 21-23 in Miami, Florida. The company’s management will host investor meetings at both events.…

MondayJan 30, 2023 10:27 am

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Issues 2023 Forecasted Revenue Anticipating >100% YOY Growth

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced revenue guidance of US$90 million to US$105 million for fiscal year 2023. Flora’s 2023 revenue guidance reflects expected organic growth in its House of Brands division and expansion of its Commercial & Wholesale division capabilities. In addition, the forecasted growth incorporates Flora’s new German-based business as established through the acquisition of Franchise Global Health. “We are pleased to announce that we will meet our guidance for 2022 and are issuing revenue guidance of $90 million - $105 million for the year 2023,”…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks